Patent · US Active

Quinoline carboxamides for use in the treatment of multiple myeloma

US9956212B2 · kind B2 · utility

1Cited by

2References

20Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

David Liberg · Lomma, SE
Anders Olsson · Stockholm, SE
Dmitry I. Gabrilovich · Villanova, US
Yuliya NEFEDOVA · Villanova, US

Key dates

Filing date	Sep 18, 2015
Grant date	May 1, 2018
Priority date	—
Expiry date	Sep 18, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D215/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of multiple myeloma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.